Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren on Progression of Atherosclerosis in CAD (AQUARIUS)
NCT00853827Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2009
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of aliskiren in coronary artery disease (CAD), Coronary atherosclerosis (CAD), sponsored by Novartis. Started Mar 2009; status: completed.
02
Drugs
aliskiren
03
Conditions
coronary artery disease (CAD)Coronary atherosclerosis (CAD)
Beyond the preview
Go deeper on NCT00853827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00853827.